Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-10-30 Purchase | 2024-11-01 7:47 pm | SANUWAVE Health Inc. | SNWVD | Opaleye Management Inc. 10% Owner | 27,868 | $15.75 | $438,902 | 12,002 (Indirect) | View |
2024-10-25 Purchase | 2024-10-28 4:05 pm | CODEXIS INC. | CDXS | Opaleye Management Inc. 10% Owner | 25,000 | $2.9088 | $72,720 | 8,545,000 (Indirect) | View |
2024-10-23 Purchase | 2024-10-25 4:05 pm | Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner | 10,000 | $7.9814 | $79,814 | 2,770,000 (Indirect) | View |
2024-10-04 Purchase | 2024-10-08 6:34 pm | Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner | 62,070 | $6.9943 | $434,137 | 82,070 (Indirect) | View |
2024-09-24 Purchase | 2024-09-26 3:21 pm | CODEXIS INC. | CDXS | Opaleye Management Inc. 10% Owner | 85,000 | $2.9311 | $249,147 | 8,520,000 (Indirect) | View |
2024-09-20 Purchase | 2024-09-23 5:19 pm | CODEXIS INC. | CDXS | Opaleye Management Inc. 10% Owner | 1,100,000 | $3.0073 | $3,308,035 | 8,435,000 (Indirect) | View |
2024-09-18 Purchase | 2024-09-19 6:16 pm | CODEXIS INC. | CDXS | Opaleye Management Inc. 10% Owner | 61,000 | $3.1638 | $192,992 | 205,000 (Indirect) | View |
2024-09-11 Sale | 2024-09-12 8:20 pm | Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner | 158,901 | $1.71 | $271,715 | 45,000 (Indirect) | View |
2024-09-10 Purchase | 2024-09-12 7:31 pm | Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner | 107,500 | $4.6965 | $504,875 | 75,000 (Indirect) | View |
2024-09-09 Sale | 2024-09-10 7:11 pm | Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner | 61,992 | $1.843 | $114,251 | 53,100 (Indirect) | View |
2024-07-16 Sale | 2024-07-18 4:05 pm | Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner | 11,396 | $2.4419 | $27,828 | 56,500 (Indirect) | View |
2024-07-09 Sale | 2024-07-11 7:56 pm | Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner | 74,551 | $2.3587 | $175,842 | 60,000 (Indirect) | View |
2024-07-01 Sale | 2024-07-03 2:00 pm | Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner | 8,288 | $2.1233 | $17,598 | 87,500 (Indirect) | View |
2024-06-27 Sale | 2024-06-28 6:45 pm | Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner | 64,568 | $2.207 | $142,503 | 85,000 (Indirect) | View |
2024-06-25 Sale | 2024-06-27 4:05 pm | Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner | 12,725 | $2.2581 | $28,734 | 102,471 (Indirect) | View |
2024-05-30 Sale | 2024-05-31 4:05 pm | Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner | 15,054 | $2.9233 | $44,008 | 108,696 (Indirect) | View |
2024-05-21 Sale | 2024-05-23 7:01 pm | Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner | 42,800 | $3.0475 | $130,434 | 123,750 (Indirect) | View |
2024-05-17 Sale | 2024-05-17 7:48 pm | Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner | 70,885 | $3.2493 | $230,326 | 126,050 (Indirect) | View |
2024-05-09 Sale | 2024-05-10 6:57 pm | Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner | 182,300 | $3.11 | $566,951 | 2,380,294 (Indirect) | View |
2024-04-25 Purchase | 2024-04-25 5:19 pm | HARROW INC. | HROW | Opaleye Management Inc. 10% Owner | 20,000 | $9.97 | $199,400 | 3,815,000 (Indirect) | View |
2024-04-23 Purchase | 2024-04-24 4:40 pm | HARROW INC. | HROW | Opaleye Management Inc. 10% Owner | 20,000 | $10.23 | $204,640 | 3,795,000 (Indirect) | View |
2024-04-19 Purchase | 2024-04-19 6:24 pm | HARROW INC. | HROW | Opaleye Management Inc. 10% Owner | 29,400 | $10.56 | $310,391 | 3,775,000 (Indirect) | View |
2024-03-28 Purchase | 2024-03-28 6:07 pm | HARROW INC. | HROW | Opaleye Management Inc. 10% Owner | 50,000 | $12.82 | $641,000 | 3,745,600 (Indirect) | View |
2024-03-20 Purchase | 2024-03-22 11:52 am | HARROW INC. | HROW | Opaleye Management Inc. 10% Owner | 50,600 | $9.65 | $488,290 | 3,695,600 (Indirect) | View |
2023-11-15 Purchase | 2023-11-16 4:05 pm | HARROW INC. | HROW | Opaleye Management Inc. 10% Owner | 25,000 | $8.0294 | $200,735 | 3,645,000 (Indirect) | View |
2023-11-10 Sale | 2023-11-14 4:05 pm | Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner | 4,764,008 | $0.2942 | $1,401,571 | 7,245,984 (Indirect) | View |
2023-09-19 Purchase | 2023-09-20 6:39 pm | HARROW HEALTH INC. | HROW | Opaleye Management Inc. 10% Owner | 20,000 | $14.6 | $292,076 | 3,620,000 (Indirect) | View |
2023-03-09 Purchase | 2023-03-13 4:05 pm | Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner | 174,508 | $1.38 | $240,821 | 11,570,492 (Indirect) | View |
2022-12-30 Sale | 2022-12-30 6:00 pm | Protara Therapeutics Inc. | TARA | Opaleye Management Inc. 10% Owner | 15,473 | $2.7111 | $41,949 | 130,000 (Indirect) | View |
2022-12-14 Purchase | 2022-12-16 5:03 pm | Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner | 167,500 | $1.253 | $209,877 | 5,671,585 (Indirect) | View |
2022-12-14 Purchase | 2022-12-14 4:05 pm | HARROW HEALTH INC. | HROW | Opaleye Management Inc. 10% Owner | 431,183 | $10.52 | $4,536,045 | 175,000 (Indirect) | View |
2022-12-06 Sale | 2022-12-08 6:49 pm | Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner | 1,539 | $1.44 | $2,216 | 13,366,585 (Indirect) | View |
2022-11-03 Purchase | 2022-11-04 4:03 pm | TELA Bio Inc. | TELA | Opaleye Management Inc. 10% Owner | 20,262 | $7.8119 | $158,285 | 124,813 (Indirect) | View |
2022-10-18 Purchase | 2022-10-19 7:22 pm | Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner | 12,500 | $1.65 | $20,625 | 9,578,124 (Indirect) | View |
2022-10-11 Purchase | 2022-10-11 7:29 pm | TELA Bio Inc. | TELA | Opaleye Management Inc. 10% Owner | 16,000 | $8 | $128,000 | 123,551 (Indirect) | View |
2022-09-29 Purchase | 2022-10-03 4:06 pm | Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner | 9,400 | $1.7415 | $16,370 | 5,863,124 (Indirect) | View |
2022-09-28 Purchase | 2022-09-30 06:15 am | HARROW HEALTH INC. | HROW | Opaleye Management Inc. 10% Owner | 11,085 | $9.7748 | $108,354 | 158,817 (Indirect) | View |
2022-09-27 Purchase | 2022-09-28 6:00 pm | Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner | 1,700 | $1.6924 | $2,877 | 5,853,724 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-09-12 4:05 pm | N/A N/A | Eton Pharmaceuticals Inc. | ETON | Opaleye Management Inc. 10% Owner | 0 | $0 | 2,672,500 (Indirect) | View |
2022-12-06 Exercise | 2022-12-08 6:49 pm | 2020-08-27 2030-08-27 | Tracon Pharmaceuticals Inc. | TCON | Opaleye Management Inc. 10% Owner | 221,539 | $0.01 | 13,366,585 (Indirect) | View |